Filter
386
Filtered Results: 386
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
42
New Publications
124
Language
Document type
No document type
203
Guidelines
64
Studies & Reports
51
Strategic & Response Plan
27
Manuals
24
Fact sheets
7
Training Material
6
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
22
Ghana
16
Uganda
16
Nigeria
15
Global
15
India
15
Western and Central Europe
13
Namibia
12
Rwanda
11
Eastern Europe
11
Nepal
10
South Africa
10
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Zambia
5
Liberia
5
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Guinea
2
Africa
2
Haiti
2
Asia
2
Latin America and the Carribbean
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Vietnam
1
Sri Lanka
1
Yemen
1
Georgia
1
Central African Republic
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
200
Clinical Guidelines
42
Public Health
9
Capacity Building
6
Women & Child Health
6
Pharmacy & Technologies
5
Key Resources
4
Toolboxes
TB
45
Pharmacy
39
AMR
32
Malaria
27
COVID-19
23
HIV
18
NTDs
15
NCDs
5
Ebola & Marburg
3
Specific Hazards
2
Refugee
2
Caregiver
2
Planetary Health
2
Rapid Response
1
Cholera
1
2.0 Rapid Response
1
Polio
1
Global Health Education
1
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Towards universal access
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
SITUATION ANALYSIS AND RECOMMENDATIONS
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
